Clinical Trials Directory

Trials / Completed

CompletedNCT05174429

The Management of Work-Disability Associated With Co-Morbid Pain and Depression: A Feasibility Study

Risk-Targeted Behavioral Activation for the Management of Work-Disability Associated With Co-Morbid Pain and Depression: A Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
McGill University · Academic / Other
Sex
All
Age
25 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of the present study was to conduct a preliminary evaluation the feasibility and impact of a risk-targeted behavioral activation intervention for work-disabled individuals with co-morbid pain and depression.

Detailed description

The design of the study was a single arm non-randomized trial. The sample consisted of 66 work-disabled individuals with co-morbid pain and depression. The treatment program consisted of a 10-week standardized behavioral activation intervention supplemented by techniques to target two psychosocial risk-factors for delayed recovery, namely, catastrophic thinking and perceptions of injustice.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRisk-Targeted Behavioral ActivationThe behavioral activation component of the treatment program focused on goal setting, structuring and scheduling activities, increasing success and achievement experiences, and problem-solving. In order to maximize the impact of behavioral activation on disability reduction, goal setting and scheduling of activities focused primarily on resumption of discontinued activities as opposed to focusing on the scheduling of pleasant activities. One objective of goal setting and activity scheduling was to reduce the discrepancy between the client's pre-injury activity repertoire and the client's current activity repertoire. Behavioral activation was supplemented by a collection of techniques designed to reduce catastrophic thinking and perceptions of injustice, two psychosocial risk factors that have been shown to contribute to prolonged work-absence.

Timeline

Start date
2016-01-10
Primary completion
2018-10-20
Completion
2018-12-15
First posted
2021-12-30
Last updated
2021-12-30

Source: ClinicalTrials.gov record NCT05174429. Inclusion in this directory is not an endorsement.